Lonza buys InterHealth Nutraceuticals for up to €267m

- Last updated on GMT


Related tags: Nutrition, Medicine, Management, Lonza

Swiss ingredients and pharma giant Lonza has agreed to pay up to $300 million (€267m) for Californian nutrient specialist InterHealth Nutraceuticals.

Lonza gains a suite of about 15 branded nutrients including its marquee collagen offering, UC-II.

“We are looking forward to welcoming the highly capable team to our Lonza family,”​ said Lonza CEO Richard Ridinger in a statement.

“They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets. Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.”

The payment is split between an up-front payment and an earn-out payment.

Lonza said InterHealth – formerly owned by Kainos Capital - would continue to operate in the same premises with the same staff.

Otgher InterHealth offering include Meratrim for weight management; Relora for stress management; ChromeMate and Zychrome for blood sugar and insulin control and CardiaSlim for  cholesterol management.

Related news

Show more

Related products

show more

Pycnogenol® Reduces Severity of Dry Mouth

Pycnogenol® Reduces Severity of Dry Mouth

Horphag Research | 18-May-2020 | Clinical Study

Newly published research shows daily supplementation with Pycnogenol® significantly reduced mouth dryness by 66% and demonstrated 82% improvement of saliva...



SABINSA | 11-May-2020 | Data Sheet

Tinospora cordifolia, used in Ayurveda for anti-aging, longevity, promoting intelligence, improving memory, and imparting immunomodulation properties,...

Related suppliers

Follow us

Featured Events

View more


View more